Skip to content

Drug interactions

Cilostazol + Lomitapide

Severity: Moderate

Cilostazol and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cilostazol is a weak CYP3A4 inhibitor and may increase lomitapide exposure, raising the risk of hepatotoxicity and gastrointestinal effects. Lomitapide has a narrow tolerability margin, and weak CYP3A4 inhibitors limit its dosing.

What this interaction means in plain words

Cilostazol and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cilostazol belongs to Cardiovascular; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Weak CYP3A4 inhibition by cilostazol reduces lomitapide metabolism.

What to do

Limit lomitapide dose per labeling when used with weak CYP3A4 inhibitors, and monitor liver enzymes and GI tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cilostazol and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cilostazol with Lomitapide?

MediHelp rates the interaction as moderate. Cilostazol and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cilostazol is a weak CYP3A4 inhibitor and may increase lomitapide exposure, raising the risk of hepatotoxicity and gastrointestinal effects. Lomitapide has a narrow tolerability margin, and weak CYP3A4 inhibitors limit its dosing.

How serious is the interaction between Cilostazol and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit lomitapide dose per labeling when used with weak CYP3A4 inhibitors, and monitor liver enzymes and GI tolerability.

What other medicines interact with Cilostazol?

MediHelp also lists interactions of Cilostazol with, for example, Abrocitinib, Anagrelide, Betrixaban. The full list is on the Cilostazol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in